Willow Biosciences Statistics
Total Valuation
CANSF has a market cap or net worth of 522,603. The enterprise value is 1.69 million.
| Market Cap | 522,603 |
| Enterprise Value | 1.69M |
Important Dates
The next estimated earnings date is Friday, May 9, 2025.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +8.29% |
| Shares Change (QoQ) | +0.85% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 112.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.16 |
| PB Ratio | -1.49 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.39 |
| EV / Sales | 0.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.65 |
Financial Position
The company has a current ratio of 0.33
| Current Ratio | 0.33 |
| Quick Ratio | 0.20 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.53 |
| Interest Coverage | -21.22 |
Financial Efficiency
Return on equity (ROE) is -422.31% and return on invested capital (ROIC) is -98.84%.
| Return on Equity (ROE) | -422.31% |
| Return on Assets (ROA) | -76.14% |
| Return on Invested Capital (ROIC) | -98.84% |
| Return on Capital Employed (ROCE) | -1,125.20% |
| Revenue Per Employee | 170,532 |
| Profits Per Employee | -226,389 |
| Employee Count | 19 |
| Asset Turnover | 1.02 |
| Inventory Turnover | 36.51 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.24% in the last 52 weeks. The beta is 1.11, so CANSF's price volatility has been higher than the market average.
| Beta (5Y) | 1.11 |
| 52-Week Price Change | -92.24% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.05 |
| Relative Strength Index (RSI) | 35.98 |
| Average Volume (20 Days) | 16,416 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CANSF had revenue of 3.24 million and -4.30 million in losses. Loss per share was -0.03.
| Revenue | 3.24M |
| Gross Profit | -274,527 |
| Operating Income | -3.88M |
| Pretax Income | -4.30M |
| Net Income | -4.30M |
| EBITDA | -3.44M |
| EBIT | -3.88M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 245,337 in cash and 1.37 million in debt, giving a net cash position of -1.12 million.
| Cash & Cash Equivalents | 245,337 |
| Total Debt | 1.37M |
| Net Cash | -1.12M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -350,977 |
| Book Value Per Share | -0.00 |
| Working Capital | -928,526 |
Cash Flow
In the last 12 months, operating cash flow was -2.59 million and capital expenditures -13,900, giving a free cash flow of -2.60 million.
| Operating Cash Flow | -2.59M |
| Capital Expenditures | -13,900 |
| Free Cash Flow | -2.60M |
| FCF Per Share | n/a |
Margins
Gross margin is -8.47%, with operating and profit margins of -119.71% and -132.75%.
| Gross Margin | -8.47% |
| Operating Margin | -119.71% |
| Pretax Margin | -132.69% |
| Profit Margin | -132.75% |
| EBITDA Margin | -106.20% |
| EBIT Margin | -119.71% |
| FCF Margin | n/a |
Dividends & Yields
CANSF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.29% |
| Shareholder Yield | -8.29% |
| Earnings Yield | -823.07% |
| FCF Yield | -497.78% |
Stock Splits
The last stock split was on May 21, 2019. It was a reverse split with a ratio of 0.04.
| Last Split Date | May 21, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.04 |
Scores
CANSF has an Altman Z-Score of -75.5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -75.5 |
| Piotroski F-Score | n/a |